logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Bob Zimmermann

University of Vienna
H指数:15
被引数:955

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase I biomarker analysis of farletuzumab ecteribulin (FZEC), formerly MORAb-202, effects on cancer responses in patients with platinum resistant ovarian cance
MOLECULAR CANCER THERAPEUTICS
IF5.5
2023-12-010
PRE
Zhang, Yan; Zimmermann, Bob; Li, Shuyu; Uenaka, Toshimitsu; Furuuchi, Keiji; Yonemori, Kan; Shimizu, Toshio; Nishio, Shin; Yunokawa, Mayu; Matsumoto, Koji; Takehara, Kazuhiro; Hasegawa, Kosei; Hirashima, Yasuyuki; Kato, Hidenori; Otake, Yohei; Miura, Takuma; Matsui, Junji; Li, Meijuan

研究方向

暂未获取到该数据
U
Ulrich Technau
H 指数:59论文数:183被引数:1.2万
R
Renée Schroeder
H 指数:46论文数:167被引数:7,254
G
Grigory Genikhovich
H 指数:25论文数:66被引数:3,862
Y
Yehu Moran
H 指数:35论文数:130被引数:3,775
O
Oleg Simakov
H 指数:42论文数:168被引数:1.2万
I
Ivana Bilusic
H 指数:9论文数:43被引数:1,726
D
Daniela Praher
H 指数:11论文数:30被引数:899
R
Rohit Dnyansagar
H 指数:7论文数:17被引数:231
N
Nicolas Robert
H 指数:29论文数:175被引数:2,620
Y
Yulia Kraus
H 指数:16论文数:56被引数:1,100